BSE: NATCOPHARM - NATCO Pharma Limited

Altı ay boyunca karlılık: -50.48%
Temettü getirisi: +0.75%

Promosyon programı NATCO Pharma Limited

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında NATCO Pharma Limited

NATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care.

daha fazla ayrıntı
The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

ISIN INE987B01026
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.9395
Дивиденд ао 6
Сайт https://www.natcopharma.co.in
Цена ао 780.8
Günlük fiyat değişimi: +0.0192% (780.8)
Haftalık fiyat değişimi: -5.35% (825.05)
Aylık fiyat değişimi: -35.81% (1216.65)
3 ayda fiyat değişimi: -45.83% (1441.75)
Altı ayda fiyat değişimi: -50.48% (1577)
Yıllık fiyat değişimi: -20.18% (978.35)
3 yılda fiyat değişimi: -7.48% (844.1)
5 yılda fiyat değişimi: +23.02% (634.8)
10 yılda fiyat değişimi: 0% (780.95)
Yılbaşından bu yana fiyat değişimi: -44.11% (1397.3)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 4.28 4
P/BV 2.91 6
P/E 12.27 8
EV/EBITDA 9.66 8
Toplam: 7.38

Yeterlik

İsim Anlam Seviye
ROA, % 22.1 7
ROE, % 25.88 8
Toplam: 6

Temettüler

İsim Anlam Seviye
Div yield, % 0.7538 1.88
DSI 0.8571 8.57
Toplam: 2.83

Görev

İsim Anlam Seviye
Debt/EBITDA 0.1605 10
Toplam: 10

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 110.76 10
karlılık Ebitda, % 12.83 2
karlılık EPS, % 206.73 10
Toplam: 8.4
Daha fazla ayrıntı

ETF Paylaşmak, % Yıllık karlılık, % Temettüler, %
iShares MSCI India Small-Cap ETF 0.34198 0.4625 0.96163
SPDR S&P Emerging Markets Small Cap ETF 0.14434 5.46 3.03583
iShares MSCI Emerging Markets Small-Cap ETF 0.1125 7.67 2.7853
WisdomTree Emerging Markets SmallCap Dividend Fund 0.09783 1.35 5.00999
WisdomTree India Earnings Fund 0.08993 5.23 1.65591
Dimensional Emerging Markets Value ETF 0.08714 17.07 4.19508
Dimensional Emerging Markets Core Equity 2 ETF 0.0739 15.96 3.34087
JPMorgan ActiveBuilders Emerging Markets Equity ETF 0.06017 9.27 3.1658
Avantis Emerging Markets Equity ETF 0.05145 8.77 3.60513
Vanguard FTSE All-World ex-US Small-Cap ETF 0.05 9.39 3.09932
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.01596 12.46 3.59676
Dimensional World ex U.S. Core Equity 2 ETF 0.01288 13.06 3.62488
iShares Core MSCI Total International Stock ETF 0.0102 6.4 3.25258
Vanguard ESG International Stock ETF 0.01 6.39 3.07501
Avantis Responsible Emerging Markets Equity ETF 0.00986 17.6 3.1719
SPDR Portfolio Emerging Markets ETF 0.00112 11.59 3.1879

Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Rajeev Nannapaneni CEO & Vice Chairman N/A 1977 (48 yıllar)
Mr. S. V. V. N. Appa Rao Chief Financial Officer N/A
Dr. Donthineni Linga Rao M.D. President of Technical Affairs & Whole Time Director N/A 1952 (73 yıl)
Mr. Venkaiah Chowdary Nannapaneni M. Pharm, MS. MD & Chairman N/A 1945 (80 yıllar)
Mr. Potluri Sivaramakrishna Prasad Executive VP of Corporate Engineering Services & Whole Time Director N/A 1958 (67 yıllar)
Mr. Chekuri Venkat Ramesh C.S. Company Secretary & Compliance Officer 3M
Dr. Pavan Ganapati Bhat Executive VP of Technical Operations & Director N/A 1967 (58 yıllar)
N. Sadasiva Rao Executive Vice President of Corporate Affairs, Legal, Secretarial & Estate Management N/A
James Rajakumar Vice President of Marketing & Sales - Domestic N/A
Nadella Malleswara Rao VP & Head of Operations

Adres: India, Hyderabad, Natco House - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.natcopharma.co.in